Related Experiment Video

Updated: Mar 28, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.2K

Network analysis predicts pembrolizumab response in advanced NSCLC with PD-L1 < 50

Mario Occhipinti1, Antonella Cruoglio2,3, Silvia Marchesi4

  • 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. mario.occhipinti@istitutotumori.mi.it.

Cancer Cell International
|March 27, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
BiomarkersData integrationDifferential co-expression networkNSCLCNetwork analysisPD-L1

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K

Related Concept Videos